Schnabel Renate, Larson Martin G, Dupuis Josée, Lunetta Kathryn L, Lipinska Izabella, Meigs James B, Yin Xiaoyan, Rong Jian, Vita Joseph A, Newton-Cheh Christopher, Levy Daniel, Keaney John F, Vasan Ramachandran S, Mitchell Gary F, Benjamin Emelia J
National Heart Lung and Blood Institute Framingham Study, Framingham, Mass., USA.
Hypertension. 2008 Jun;51(6):1651-7. doi: 10.1161/HYPERTENSIONAHA.107.105668. Epub 2008 Apr 21.
Inflammation causes vascular dysfunction and perpetuates proatherosclerotic processes. We hypothesized that a broad panel of inflammatory biomarkers and single nucleotide polymorphisms in inflammatory genes is associated with vascular stiffness. We assessed 12 circulating inflammatory biomarkers (C-reactive protein, fibrinogen, interleukin-6, intercellular adhesion molecule-1, lipoprotein-associated phospholipase-A2 [mass and activity], monocyte chemoattractant protein-1, myeloperoxidase, CD40 ligand, osteoprotegerin, P-selectin, and tumor necrosis factor receptor-II) in relation to tonometry variables (central pulse pressure, mean arterial pressure, forward pressure wave, reflected pressure wave, carotid-femoral pulse wave velocity, and augmentation index) measured in 2409 Framingham Heart Study participants (mean age: 60 years; 55% women; 13% ethnic/racial minorities). Single nucleotide polymorphisms (n=2195) in 240 inflammatory candidate genes were related to tonometry measures in 1036 white individuals. In multivariable analyses, biomarkers explained <1% of any tonometry measure variance. Applying backward elimination, markers related to tonometry (P<0.01) were as follows: tumor necrosis factor receptor-II (inversely) with mean arterial pressure; C-reactive protein (positively) and lipoprotein-associated phospholipase-A2 (inversely) with reflected pressure wave; and interleukin-6 and osteoprotegerin (positively) with carotid-femoral pulse wave velocity. In genetic association analyses, lowest P values (false discovery rate <0.50) were observed for rs10509561 (FAS), P=6.6x10(-5) for central pulse pressure and rs11559271 (ITGB2), P=1.1x10(-4) for mean arterial pressure. These data demonstrate that, in a community-based sample, circulating inflammatory markers tumor necrosis factor receptor-II (mean arterial pressure), C-reactive protein, lipoprotein-associated phospholipase-A2 activity (reflected pressure wave), interleukin-6, and osteoprotegerin (carotid-femoral pulse wave velocity) were significantly but modestly associated with measures of arterial stiffness and wave reflection. Additional studies are needed to determine whether variation in inflammatory marker genes is associated with tonometry measures.
炎症会导致血管功能障碍,并使动脉粥样硬化进程持续存在。我们假设一系列广泛的炎症生物标志物以及炎症基因中的单核苷酸多态性与血管僵硬度相关。我们评估了12种循环炎症生物标志物(C反应蛋白、纤维蛋白原、白细胞介素-6、细胞间黏附分子-1、脂蛋白相关磷脂酶A2[质量和活性]、单核细胞趋化蛋白-1、髓过氧化物酶、CD40配体、骨保护素、P选择素和肿瘤坏死因子受体II)与眼压测量变量(中心脉压、平均动脉压、正向压力波、反射压力波、颈股脉搏波速度和增强指数)之间的关系,这些变量是在2409名弗雷明汉心脏研究参与者(平均年龄:60岁;55%为女性;13%为少数族裔)中测量的。240个炎症候选基因中的单核苷酸多态性(n = 2195)与1036名白人个体的眼压测量指标相关。在多变量分析中,生物标志物对任何眼压测量指标方差的解释均小于1%。采用向后排除法,与眼压测量相关(P < 0.01)的标志物如下:肿瘤坏死因子受体II(呈负相关)与平均动脉压;C反应蛋白(呈正相关)和脂蛋白相关磷脂酶A2(呈负相关)与反射压力波;白细胞介素-6和骨保护素(呈正相关)与颈股脉搏波速度。在基因关联分析中,rs10509561(FAS)的P值最低(错误发现率 < 0.50),中心脉压的P = 6.6×10⁻⁵,rs11559271(ITGB2)的P = 1.1×10⁻⁴,平均动脉压的P值为该值。这些数据表明,在一个基于社区的样本中,循环炎症标志物肿瘤坏死因子受体II(平均动脉压)、C反应蛋白、脂蛋白相关磷脂酶A2活性(反射压力波)、白细胞介素-6和骨保护素(颈股脉搏波速度)与动脉僵硬度和波反射测量指标显著但适度相关。需要进一步的研究来确定炎症标志物基因的变异是否与眼压测量指标相关。